A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant

This study has been terminated.

Study NCT00576602 Information provided by Hoffmann-La Roche

First Received: December 18, 2007 Last Updated: September 22, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	February 2010
Estimated Primary Completion Date:	No date given